ENTA

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) is a biotechnology company founded in 1995 and headquartered in Watertown, Massachusetts. The company specializes in discovering and developing small molecule drugs for treating viral infections and liver diseases. Enanta went public in March 2013 and has established itself as a focused developer of antiviral therapeutics, with a particular emphasis on respiratory viruses and hepatitis treatments. The company operates primarily as a research and development organization, with revenue generated through royalty agreements from previously developed drugs and ongoing clinical development programs.